Søren Jensen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Tecleaf ApS | Chairman | - | - |
| Samfonden | Director/Board Member | - | - |
| Fulton Foundation | Director/Board Member | - | - |
Career history of Søren Jensen
Former positions of Søren Jensen
| Companies | Position | Start | End |
|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Director/Board Member | 2021-07-30 | 2023-02-03 |
| Independent Dir/Board Member | 2021-07-30 | 2023-02-03 | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Board Member | 2020-08-31 | - |
| Independent Dir/Board Member | 2020-08-31 | - |
Training of Søren Jensen
| University of Aarhus | Graduate Degree |
Statistics
International
| Denmark | 5 |
| United States | 3 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
| Tecleaf ApS | |
| Samfonden | |
| Fulton Foundation |
- Stock Market
- Insiders
- Søren Jensen
- Experience
